Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 81 articles:
HTML format



Single Articles


    April 2022
  1. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    PubMed     Abstract available


  2. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available


  3. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    PubMed     Abstract available


    March 2022
  4. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
    PubMed    


  5. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    PubMed     Abstract available


  6. BARBIELLINI AMIDEI C, Trevisan C, Dotto M, Ferroni E, et al
    Association of physical activity trajectories with major cardiovascular diseases in elderly people.
    Heart. 2022;108:360-366.
    PubMed     Abstract available


  7. WANG X, Dong JY, Cui R, Muraki I, et al
    Smoking cessation, weight gain and risk of cardiovascular disease.
    Heart. 2022;108:375-381.
    PubMed     Abstract available


    February 2022
  8. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available


  9. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.
    PubMed    


    January 2022
  10. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    PubMed    


    December 2021
  11. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.
    PubMed    


  12. FRAISSE A, Hascoet S, Kempny A
    Closing atrial septal defects for prevention of stroke: how small is too small?
    Heart. 2021;107:1850-1851.
    PubMed    


  13. DOLGNER SJ, Steinberg ZL, Jones TK, Reisman M, et al
    Stroke in patients with secundum atrial septal defect and sequelae after transcatheter closure.
    Heart. 2021;107:1875-1880.
    PubMed     Abstract available


    October 2021
  14. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    PubMed     Abstract available


  15. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available


  16. ARORA GK, Kumar Gupta P, Bansal S
    Transient ischaemic attack in a young woman.
    Heart. 2021;107:1629-1682.
    PubMed    


    September 2021
  17. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    PubMed     Abstract available


    August 2021
  18. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available


  19. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available


    July 2021
  20. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available


  21. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available


    June 2021
  22. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    PubMed    


  23. TAM DY, Rocha RV, Fang J, Ouzounian M, et al
    Multiple arterial coronary bypass grafting is associated with greater survival in women.
    Heart. 2021;107:888-894.
    PubMed     Abstract available


    May 2021
  24. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    PubMed     Abstract available


  25. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
    PubMed    


  26. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available


  27. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    PubMed     Abstract available


  28. PARK J, Yoon YE, Kim KM, Hwang IC, et al
    Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women.
    Heart. 2021 May 7. pii: heartjnl-2020-318764. doi: 10.1136/heartjnl-2020-318764.
    PubMed     Abstract available


  29. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.
    PubMed    


  30. KARTHIKEYAN G
    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.
    PubMed    


    April 2021
  31. BUCHAN TA, Malik A, Chan C, Chambers J, et al
    Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
    Heart. 2021 Apr 8. pii: heartjnl-2021-319243. doi: 10.1136/heartjnl-2021-319243.
    PubMed     Abstract available


  32. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    PubMed     Abstract available


  33. SCOTT ML, Murnane KS, Orr AW
    Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young.
    Heart. 2021;107:604-606.
    PubMed    


  34. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    PubMed     Abstract available


    March 2021
  35. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    PubMed     Abstract available


  36. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    PubMed     Abstract available


    February 2021
  37. LOWRES N, Giskes K, Freedman B
    Next frontier in management of atrial fibrillation.
    Heart. 2021 Feb 23. pii: heartjnl-2021-318961. doi: 10.1136/heartjnl-2021-318961
    PubMed    


    January 2021
  38. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available


  39. MALLINSON PAC, Luhar S, Williamson E, Barreto ML, et al
    Socioeconomic position and cardiovascular mortality in 63 million adults from Brazil.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318153. doi: 10.1136/heartjnl-2020-318153
    PubMed     Abstract available


  40. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    PubMed     Abstract available


  41. MAZNYCZKA AM, McCartney P, Duklas P, McEntegart M, et al
    Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial.
    Heart. 2021 Jan 12. pii: heartjnl-2020-317828. doi: 10.1136/heartjnl-2020-317828
    PubMed     Abstract available


  42. VASCONCELOS M, Vasconcelos L, Ribeiro V, Campos C, et al
    Incidence and predictors of stroke in patients with rheumatic heart disease.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318054. doi: 10.1136/heartjnl-2020-318054.
    PubMed     Abstract available


  43. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available


  44. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.
    PubMed    


  45. OTTO CM
    Heartbeat: increased use of NOACs in patients with atrial fibrillation reduces health care system costs by reducing stroke incidence.
    Heart. 2021;107:1-3.
    PubMed    


    December 2020
  46. O' DONNELL M, Hankey GJ, Rangarajan S, Chin SL, et al
    Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level.
    Heart. 2020 Dec 14. pii: heartjnl-2019-316515. doi: 10.1136/heartjnl-2019-316515
    PubMed     Abstract available


  47. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    PubMed     Abstract available


  48. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    PubMed     Abstract available


    November 2020
  49. SANJOY S, Choi YH, Holmes D, Herrman H, et al
    Comorbidity burden in patients undergoing left atrial appendage closure.
    Heart. 2020 Nov 23. pii: heartjnl-2020-317741. doi: 10.1136/heartjnl-2020-317741
    PubMed     Abstract available


    October 2020
  50. SEIFFGE DJ, Meinel TR
    The real prize of direct oral anticoagulant blockbuster.
    Heart. 2020 Oct 28. pii: heartjnl-2020-318092. doi: 10.1136/heartjnl-2020-318092
    PubMed    


  51. ORLOWSKI A, Gale CP, Ashton R, Petrungaro B, et al
    Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-317006. doi: 10.1136/heartjnl-2020-317006
    PubMed     Abstract available


  52. BARRA S, Providencia R
    Anticoagulation in atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-316728. doi: 10.1136/heartjnl-2020-316728
    PubMed    


  53. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    PubMed     Abstract available


    August 2020
  54. KJERPESETH LJ, Igland J, Selmer R, Ellekjaer H, et al
    Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.
    Heart. 2020 Aug 20. pii: heartjnl-2020-316624. doi: 10.1136/heartjnl-2020-316624
    PubMed     Abstract available


  55. MAEDA T, Nishi T, Funakoshi S, Tada K, et al
    Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).
    Heart. 2020 Aug 14. pii: heartjnl-2020-317299. doi: 10.1136/heartjnl-2020-317299
    PubMed     Abstract available


  56. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.
    PubMed    


    July 2020
  57. DING WY, Gupta D, Lip GYH
    Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Heart. 2020 Jul 16. pii: heartjnl-2020-316977. doi: 10.1136/heartjnl-2020-316977
    PubMed     Abstract available


  58. LYCKHAGE LF, Hansen ML, Toft JC, Larsen SL, et al
    Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care.
    Heart. 2020 Jul 3. pii: heartjnl-2020-316904. doi: 10.1136/heartjnl-2020-316904.
    PubMed     Abstract available


    May 2020
  59. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726
    PubMed    


  60. BURDEN AF
    Tub bathing and heart disease.
    Heart. 2020;106:710.
    PubMed    


    April 2020
  61. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available


  62. CHATEAUNEUF G, Nazif TM, Beaupre F, Kodali S, et al
    Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316331. doi: 10.1136/heartjnl-2019-316331
    PubMed     Abstract available


  63. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    PubMed    


    March 2020
  64. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available


  65. UKAI T, Iso H, Yamagishi K, Saito I, et al
    Habitual tub bathing and risks of incident coronary heart disease and stroke.
    Heart. 2020 Mar 24. pii: heartjnl-2019-315752. doi: 10.1136/heartjnl-2019-315752
    PubMed     Abstract available


  66. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.
    PubMed    


    February 2020
  67. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    PubMed     Abstract available


    January 2020
  68. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957
    PubMed    


  69. LU J, Zhang L, Lu Y, Su M, et al
    Secondary prevention of cardiovascular disease in China.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315884. doi: 10.1136/heartjnl-2019-315884
    PubMed     Abstract available


  70. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    PubMed     Abstract available


    November 2019
  71. CHRISTERSSON C, James SK, Lindhagen L, Ahlsson A, et al
    Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
    Heart. 2019 Nov 22. pii: heartjnl-2019-315453. doi: 10.1136/heartjnl-2019-315453
    PubMed     Abstract available


    October 2019
  72. YU CW
    Does thrombectomy inhibit effect of ischaemic postconditioning in STEMI? True or not?
    Heart. 2019 Oct 14. pii: heartjnl-2019-315389. doi: 10.1136/heartjnl-2019-315389
    PubMed    


  73. BANERJEE A, Benedetto V, Gichuru P, Burnell J, et al
    Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Heart. 2019 Oct 10. pii: heartjnl-2019-315307. doi: 10.1136/heartjnl-2019-315307
    PubMed     Abstract available


  74. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Abstract available


    September 2019
  75. WU VC, Wu M, Aboyans V, Chang SH, et al
    Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation.
    Heart. 2019 Sep 26. pii: heartjnl-2019-315065. doi: 10.1136/heartjnl-2019-315065
    PubMed     Abstract available


  76. JAME S, Barnes G
    Stroke and thromboembolism prevention in atrial fibrillation.
    Heart. 2019 Sep 18. pii: heartjnl-2019-314898. doi: 10.1136/heartjnl-2019-314898
    PubMed     Abstract available


    August 2019
  77. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Abstract available


    June 2019
  78. MALIK AH, Yandrapalli S, Aronow WS, Panza JA, et al
    Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
    Heart. 2019 Jun 14. pii: heartjnl-2019-314767. doi: 10.1136/heartjnl-2019-314767
    PubMed     Abstract available


    May 2019
  79. LINDHOLM D, Sarno G, Erlinge D, Svennblad B, et al
    Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction.
    Heart. 2019 May 4. pii: heartjnl-2018-314590. doi: 10.1136/heartjnl-2018-314590.
    PubMed     Abstract available


    April 2019
  80. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    PubMed     Abstract available


    March 2019
  81. POKORNEY SD, Lopes RD
    Atrial fibrillation: what do we know about screening and what do we not know about treatment?
    Heart. 2019 Mar 21. pii: heartjnl-2018-314518. doi: 10.1136/heartjnl-2018-314518
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: